|
|
|
Insider
Information: |
Spurr Robert |
Relationship: |
President, U.S. Busine... |
City: |
Waltham |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
122,741 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,187,776 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
122,741 |
|
|
Total
Value |
$2,187,776 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Repligen Corp |
RGEN |
Officer |
2012-03-12 |
10,000 |
|
0 |
Premium* |
|
Bausch Health Companies Inc |
BHC |
President, U.S. Busine... |
2022-05-10 |
112,741 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BHC |
Bausch Health Companies I... |
U.S. President-Pharma Business |
|
2022-03-02 |
4 |
A |
$24.17 |
$861,105 |
D/D |
35,627 |
101,021 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
U.S. President-Pharma Business |
|
2022-02-27 |
4 |
D |
$24.35 |
$177,682 |
D/D |
(7,297) |
66,989 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
U.S. President-Pharma Business |
|
2022-03-15 |
4 |
AS |
$22.20 |
$107,581 |
D/D |
(4,846) |
92,101 |
0 |
% |
|
BHC |
Bausch Health Companies I... |
President, Salix |
|
2021-03-01 |
4 |
D |
$31.42 |
$102,178 |
D/D |
(3,252) |
35,444 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
U.S. President-Pharma Business |
|
2022-03-03 |
4 |
D |
$23.61 |
$96,187 |
D/D |
(4,074) |
96,947 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
U.S. President-Pharma Business |
|
2022-01-18 |
4 |
AS |
$26.63 |
$86,574 |
D/D |
(3,251) |
63,550 |
0 |
% |
|
BHC |
Bausch Health Companies I... |
U.S. President-Pharma Business |
|
2022-02-15 |
4 |
AS |
$25.02 |
$81,340 |
D/D |
(3,251) |
60,299 |
0 |
% |
|
BHC |
Bausch Health Companies I... |
U.S. President-Pharma Business |
|
2022-02-26 |
4 |
D |
$24.35 |
$39,642 |
D/D |
(1,628) |
68,640 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
U.S. President-Pharma Business |
|
2022-03-02 |
4 |
AS |
$23.37 |
$37,275 |
D/D |
(1,595) |
65,394 |
0 |
% |
|
BHC |
Bausch Health Companies I... |
President, Salix |
|
2021-08-27 |
4 |
D |
$28.95 |
$36,998 |
D/D |
(1,278) |
58,058 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
President, Salix |
|
2020-08-28 |
4 |
D |
$17.00 |
$21,726 |
D/D |
(1,278) |
38,972 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
U.S. President-Pharma Business |
|
2021-10-01 |
4 |
D |
$28.60 |
$8,094 |
D/D |
(283) |
66,801 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
President, Salix |
|
2020-10-02 |
4 |
D |
$15.89 |
$4,386 |
D/D |
(276) |
38,696 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
President, Salix |
|
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
23,892 |
59,336 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
President, Salix |
|
2021-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,026 |
67,084 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
U.S. President-Pharma Business |
|
2022-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,615 |
75,914 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
President, U.S. Businesses |
|
2022-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,235 |
112,741 |
0 |
- |
|
RGEN |
Repligen Corp |
Chief Commercial. OfficerOffic |
|
2012-03-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
- |
|
BHC |
Bausch Health Companies I... |
President, SalixOfficer |
|
2020-05-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,250 |
|
% |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|